In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Stable Coronary Artery Disease (Management of)

ESC Clinical Practice Guidelines

These guidelines should be applied to patients with stable known or suspected coronary artery disease (SCAD).

The web addenda to the 2013 SCAD Guidelines contains additional material which should be used for further clarifications when reading the main document. The numbering of the chapters in this web document corresponds to the chapter numbering in the main document.

EMA and ESC statements on ivabradine
Coronary Intervention
Chronic Ischaemic Heart Disease (IHD)
Cardiovascular Surgery
Guidelines version available to download
Published in 2013
Reference Eur Heart J 2013;34:2949–3003 - doi:10.1093/eurheartj/eht296
Published in 2014
Reference Corrigendum SCAD
Published in 2013
Published in 2013
Published in 2013
Reference ANGINA
Published in 2013
Reference Web Addenda
Table of contents: Full Text (ESC Clinical Practice Guidelines)
  • Preamble
  • Introduction
  • Definition & pathophysiology (see web addenda)
  • Epidemiology
  • Natural history and prognosis
  • Diagnosis and assessemnt (see web addenda)
    • Symptoms and signs (see web addenda), non-invasive cardiac investigations, invasive coronary angiography (see web addenda), stratification for risk of events (see web addenda), diagnostic aspects in the asymptomatic individual without known coronary artery disease (see web addenda), management aspects in the patient with known coronary artery disease, special diagnostic considerations:angina with 'normal' coronary arteries (see web addenda)
  • Lifestyle and pharmacological management
    • Risk factors and ischaemia management, event prevention, other drugs, strategy, treatment of particular forms of SCAD
  • Revascularization
    • Percutaneous coronary invervention,coronary artery bypass surgery, revascularization vs. medical therapy, percutaneous coronary intervention vs. coronary artery bypass graft (see web addenda), scores and decisions (see web addenda)
  • Special groups or considerations
    • Women (see web addenda), patients with diabetes (see web addenda), patients with chronic kidney disease (see web addenda), elderly patients (see web addenda), the patient after revascularization (see web addenda), repeart revascularization of the patient with prior coronary artery bypass graft revascularization (see web addenda), chronic total occlusions (see web addenda), refractory angina (see web addenda), primary care (see web addenda), gaps in evidence (see web addenda)




Back to top
European Society
of Cardiology

Les Templiers
2035 Route des Colles
CS 80179 BIOT
06903 Sophia Antipolis
Cedex France